top of page

KSL Management Team

kevin.jpg

KEVIN LAWSON

Partner

Kevin is an accomplished biotechnology executive with formidable experience identifying and building value in promising new technologies through collaborative licensing and internal basic research. Working closely with regulatory authorities at all levels: departments of health, FDA and international bodies, he has driven development, regulatory clearance and commercialization of numerous novel reference laboratory tests and IVDs in the US and rest of world. He is responsible for validation and approval of many LDTs and 510k of more than 50 assays and medical devices.

Suresh.jpg

LAKSHMANAN SURESH, DDS, MS, PhD

Partner

Dr. Suresh is a world-class scientist with broad experience in oral surgery, immunology, diagnostics and pathology. He is board-certified in Oral and Maxillofacial Pathology by the American Board of Oral and Maxillofacial Pathology. He is also board certificated in Laboratory Immunology by American Board of Medical Laboratory Immunology. He has authored numerous publications and book chapters, holds several patents and maintains research collaborations around the world. He is a Clinical Professor at the State University of New York at Buffalo.

long.jpg

LONG SHEN, PhD

Partner

Dr. Long Shen is a founding partner of KSL Biomedical. Drawing upon scientific and medical training in Xiamen University, China and The University at Buffalo, USA, he has performed as translational biomedical research innovative scientific program leader for over 15 years in academic programs and private industry. Dr. Shen has made significant contributions to the identification of novel biomarkers for the early diagnosis of autoimmune disease and associated B-cell lymphomas. Dr. Shen has authored more than 25 peer-reviewed publications in high impact research journals and is co-inventor on a number patents in this field. 

bottom of page